Filippo de Marinis
- Pulmonary and Respiratory Medicine top 0.02%
- Oncology top 0.05%
- Molecular Biology top 1%
- Cancer Research top 0.5%
- Surgery top 5%
- Co-authors
- Joachim von PawelU. GatzemeierGiorgio V. ScagliottiKeunchil ParkChristian ManegoldAntonio PassaroJose R. PereiraCesare Gridelli
- Topics
- Lung Cancer Treatments and Mutations (362 papers)Lung Cancer Research Studies (182 papers)Lung Cancer Diagnosis and Treatment (160 papers)
- Partner nations
- ItalyUnited StatesSpain
In The Last Decade
Filippo de Marinis
436 papers receiving 18.5k citations
Hit Papers
Peers
Comparison fields: 5 of 144
- Pulmonary and Respiratory Medicine 14.8k
- Oncology 13.4k
- Molecular Biology 4.0k
- Cancer Research 2.7k
- Surgery 1.1k
Countries citing papers authored by Filippo de Marinis
This map shows the geographic impact of Filippo de Marinis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Filippo de Marinis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Filippo de Marinis more than expected).
Fields of papers citing papers by Filippo de Marinis
This network shows the impact of papers produced by Filippo de Marinis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Filippo de Marinis. The network helps show where Filippo de Marinis may publish in the future.
Co-authorship network of co-authors of Filippo de Marinis
This figure shows the co-authorship network connecting the top 25 collaborators of Filippo de Marinis. A scholar is included among the top collaborators of Filippo de Marinis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Filippo de Marinis. Filippo de Marinis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | Lorlatinib Versus Crizotinib in Patients With Advanced ALK -Positive Non–Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN Studybreakdown → | 118 |
| 4 | 1 | |
| 5 | 4 | |
| 6 | 2 | |
| 7 | 50 | |
| 8 | 1 | |
| 9 | 2 | |
| 10 | 4 | |
| 11 | 4 | |
| 12 | 37 | |
| 13 | 1 | |
| 14 | 12 | |
| 15 | 14 | |
| 16 | Capmatinib in patients with high-level MET-amplified advanced non-small cell lung cancer (NSCLC): results from the phase 2 GEOMETRY mono-1 study | 8 |
| 17 | 135 | |
| 18 | 18 | |
| 19 | EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX studybreakdown → | 453 |
| 20 | Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancerbreakdown → | 2487 |
About Filippo de Marinis
Filippo de Marinis is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 450 papers that have together received 19.0k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (362 papers), Lung Cancer Research Studies (182 papers) and Lung Cancer Diagnosis and Treatment (160 papers). The work is most often cited by research in Oncology (13.4k citations), Pulmonary and Respiratory Medicine (14.8k citations) and Cancer Research (2.7k citations). Filippo de Marinis has collaborated with scholars based in Italy, United States and Spain. Frequent co-authors include Joachim von Pawel, U. Gatzemeier, Giorgio V. Scagliotti, Keunchil Park, Christian Manegold, Antonio Passaro, Jose R. Pereira, Cesare Gridelli, Tony Mok and Johan Vansteenkiste. Their work appears in journals such as New England Journal of Medicine, The Lancet and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.